Institut Mérieux has returned for a $26.5m round for surgical technology developer Keranova, having previously supported a $4.6m round three and a half years ago.
France-based cataract treatment developer Keranova has raised €24m ($26.5m) in funding from investors including Mérieux Equity Partners, an investment vehicle for medical holding group Institut Mérieux, according to La Tribune.
Supernova Invest, Financière Arbevel, Tourrette Investissement and several undisclosed international investors also took part in the round.
Keranova is working on non-invasive surgical technology that will combine robotics and a high-speed laser with imaging technology to assist the surgeon who will theoretically be able to cure cataracts in under a…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
